Clinical impact of tumor-infiltrating inflammatory cells in primary small cell esophageal carcinoma
- PMID: 24886814
- PMCID: PMC4100116
- DOI: 10.3390/ijms15069718
Clinical impact of tumor-infiltrating inflammatory cells in primary small cell esophageal carcinoma
Abstract
Primary small cell esophageal carcinoma is a rare and aggressive type of gastrointestinal cancer with poor prognosis. In the present study, the impact of tumour infiltrating inflammatory cells on clinico-pathological characteristics and the patients' prognosis were analysed. A total of 36 small cell esophageal carcinomas, 19 adjacent normal tissues and 16 esophageal squamous cell carcinoma samples were collected. Qualified pathologists examined eosinophils, neutrophils, lymphocytes and macrophages on histochemical slides. The infiltration of eosinophils and macrophages in small cell esophageal carcinoma was significantly increased as compared with tumor adjacent normal tissues, and was significantly less in esophageal squamous cell carcinoma. Macrophage count was significantly associated with (p = 0.015) lymph node-stage in small cell esophageal carcinoma. When we grouped patients into two groups by counts of infiltrated inflammatory cells, Kaplan-Meier analysis revealed that high macrophage infiltration group (p = 0.004) and high eosinophil infiltration group (p = 0.027) had significantly enhanced survival. In addition, multivariate analysis unveiled that eosinophil count (p = 0.002) and chemotherapy (Yes vs. No, p = 0.001) were independent prognostic indicators. Taken together, infiltration of macrophages and eosinophils into the solid tumor appear to be important in the progression of small cell esophageal carcinoma and patients' prognosis.
Figures


Similar articles
-
Significance of tumor associated tissue eosinophilia and other inflammatory cell infiltrate in early esophageal squamous cell carcinoma.Anticancer Res. 2000 Sep-Oct;20(5A):3025-30. Anticancer Res. 2000. PMID: 11062718
-
CD163 as a marker of M2 macrophage, contribute to predicte aggressiveness and prognosis of Kazakh esophageal squamous cell carcinoma.Oncotarget. 2017 Mar 28;8(13):21526-21538. doi: 10.18632/oncotarget.15630. Oncotarget. 2017. PMID: 28423526 Free PMC article.
-
Tumor-associated macrophages and CD3-zeta expression of tumor-infiltrating lymphocytes in human esophageal squamous-cell carcinoma.Dis Esophagus. 2007;20(2):107-16. doi: 10.1111/j.1442-2050.2007.00655.x. Dis Esophagus. 2007. PMID: 17439593
-
Prognostic significance of the lymphocyte-to-monocyte ratio and the tumor-infiltrating lymphocyte to tumor-associated macrophage ratio in patients with stage T3N0M0 esophageal squamous cell carcinoma.Cancer Immunol Immunother. 2017 Mar;66(3):343-354. doi: 10.1007/s00262-016-1931-5. Epub 2016 Dec 3. Cancer Immunol Immunother. 2017. PMID: 27915370 Free PMC article.
-
The clinical significance of tumor-infiltrating neutrophils and neutrophil-to-CD8+ lymphocyte ratio in patients with resectable esophageal squamous cell carcinoma.J Transl Med. 2014 Jan 7;12:7. doi: 10.1186/1479-5876-12-7. J Transl Med. 2014. PMID: 24397835 Free PMC article.
Cited by
-
The oncogenic roles of nuclear receptor coactivator 1 in human esophageal carcinoma.Cancer Med. 2018 Oct;7(10):5205-5216. doi: 10.1002/cam4.1786. Epub 2018 Sep 30. Cancer Med. 2018. PMID: 30270520 Free PMC article.
-
Opposing roles of eosinophils in cancer.Cancer Immunol Immunother. 2019 May;68(5):823-833. doi: 10.1007/s00262-018-2255-4. Epub 2018 Oct 9. Cancer Immunol Immunother. 2019. PMID: 30302498 Free PMC article. Review.
-
Tumor-associated tissue eosinophilia predicts favorable clinical outcome in solid tumors: a meta-analysis.BMC Cancer. 2020 May 20;20(1):454. doi: 10.1186/s12885-020-06966-3. BMC Cancer. 2020. PMID: 32434481 Free PMC article.
-
Comprehensive Analysis of Tumor-Infiltrating Immune Cells and Relevant Therapeutic Strategy in Esophageal Cancer.Dis Markers. 2020 May 11;2020:8974793. doi: 10.1155/2020/8974793. eCollection 2020. Dis Markers. 2020. PMID: 32454908 Free PMC article.
-
Tumor-Infiltrating Immune Cells and PD-L1 as Prognostic Biomarkers in Primary Esophageal Small Cell Carcinoma.J Immunol Res. 2020 Dec 29;2020:8884683. doi: 10.1155/2020/8884683. eCollection 2020. J Immunol Res. 2020. PMID: 33457428 Free PMC article.
References
-
- Lam K.Y., Law S., Tung P.H., Wong J. Esophageal small cell carcinomas: Clinicopathologic parameters, p53 overexpression, proliferation marker, and their impact on pathogenesis. Arch. Pathol. Lab. Med. 2000;124:228–233. - PubMed
-
- Sadanaga N., Morita M., Masuda T., Okada S., Sugiyama M., Ando K., Kakeji Y., Matsuura H., Maehara Y. Clinical features of primary small cell carcinoma of the thoracic esophagus: A retrospective analysis of 12 surgically resected cases. Esophagus. 2009;6:161–165. doi: 10.1007/s10388-009-0197-9. - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical